MDM2 and neoplasm: As initially identified as a p53-interacting molecule, RITA was reported to bind to the p53 N-terminal domain, probably leading to conformational changes, thus impeding the p53/MDM2 interaction and resulting in p53 accumulation, tumor cell growth inhibition, and p53-dependent cell apoptosis in vitro and in vivo [39].